How oncology pharmacy leaders fight burnout with stay surveys, smarter schedules, and recognition—building resilient teams through loss and turnover.
|Articles|January 1, 2006
- Volume 0 0
WTO APPROVES STEPS TO ENHANCE DRUG ACCESS
Advertisement
The World TradeOrganization (WTO) hastaken action to helpdeveloping countrieshave access to genericmedications for communicable diseasessuch as AIDS. The approved changes tothe WTO's intellectual property agreementwould make permanent a waivercurrently in place and allow economicallystrapped countries lacking pharmaceuticalmanufacturing capacities toimport cheaper copies of patented medicinesfor humanitarian purposes.
The organization has set December 1,2007, as a deadline to approve theamendment. The revision would need tobe approved by two thirds of the 148members.
Articles in this issue
almost 21 years ago
Resealable and Nultraviolet Ultraviolet (UV) Inhibitant Bagsalmost 21 years ago
High Alert Insulin Binalmost 21 years ago
Hydase (hyaluronidase injection, USP)almost 21 years ago
Humira (adalimumab)almost 21 years ago
INVANZ (ertapenem for injection)almost 21 years ago
Compounding HOTLINEalmost 21 years ago
Customer Guilty of Prescription Fraud by Supporting Friendalmost 21 years ago
Counterfeit Drugs: A Life-or-Death Problemalmost 21 years ago
Qui Tam Lawsuits Blow the Whistle on PBMsalmost 21 years ago
Can You Read These Rxs?Advertisement
Related to this article
At-home chemotherapy for HR+ breast cancer works best when pharmacists guide oral regimens, boosting adherence, safety, and affordable access.
Managing medication safety in specialized populations requires a shift from standardized dosing to precise, patient-specific customization.
Sometimes, a breakthrough matters not only because of what it does for patients today, but because of what it makes possible for tomorrow.
Pharmacogenomic-guided prescribing uses genetic data to protect patients from dangerous toxicities and get them the right drug at the right dose from the start.
As accessible health care providers, pharmacists can raise awareness about the proper use of OTC blood glucose meters and continuous glucose monitoring devices.
Growing evidence points to gallstones and cholecystitis as an underrecognized risk of GLP-1 RA therapy—pharmacists are well positioned to catch it early.
As earning years peak, so do spending and responsibility—here’s where midcareer pharmacists should focus their financial decision-making.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Pneumonic Plague: What Pharmacists Need to Know About Treatment
2
Preparing Pharmacists for Psychedelic Medicine
3
FDA Approves Pritelivir for Refractory HSV Lesions in Immunocompromised Adults
4
FDA Approves First Once-Monthly Subcutaneous Olanzapine LAI for Adults With Schizophrenia
5